How much does disease depress development in human capital and income around the world? I discuss a range of micro evidence, which finds that health is both human capital itself and an input to producing other forms of human capital. I use a standard model to integrate these results, and suggest a re-interpretation of much of the micro literature. I then discuss the aggregate implications of micro estimates, but note the complications in extrapolating to general equilibrium, especially because of health's effect on population size. I also review the macro evidence on this topic, which consists of either cross-country comparisons or measuring responses to health shocks. Micro estimates are 1-2 orders of magnitude smaller than the crosscountry relationship, but nevertheless imply high benefit-to-cost ratios from improving certain forms of health.
INTRODUCTION
Poor countries tend to be unhealthy, and unhealthy countries tend to be poor. Across the broad swath of history, improvements in income have come hand-in-hand with improvements in health.
Further, the poorest countries of the world are in the tropics, an area rife with tropical disease.
These stylized facts lead to a natural question: does disease hold back development? It seems possible that it would. Health is a form of human capital as well as an input to producing other forms of human capital. Being unhealthly depresses the ability to work productively and/or the ability and incentives to invest in human capital. Taken together, these mechanisms imply that worse health implies lower income. But is this enough to account for the stylized facts above?
The correlation between health and development is hard to interpret simply as the causal effect of health on income. Third factors such as bad government or geographic disadvantages might impede both productivity and disease control. Also, health is also a normal good: when people get richer, they invest more in their own health, and exhort their governments to spend more on public health. The correlation between health and income might be one of circular and cumulative causation: health affects income and income affects health and so on.
This review is organized around the following question: in the aggregate, how much does disease depress income and human capital? The answer to this question would help us understand the global distribution of income and also inform us about the rate of return on health policies.
I start with a review of micro-empirical studies, where the evidence is most compelling, but less tightly linked to the original question, and then move to macro, where the evidence is less compelling, but better linked to the original question. I discuss evidence drawn both from developing countries today and from the historical experience of now-developed regions. The micro-empirical literature that I review is somewhat disconnected from economic theory, so I also use some stylized models to sort things out. The models help determine if a given result is of 'first order' importance, which is to say whether health has, to a first approximation, any effect at all on income.
I limit the scope of this review in a few ways. First, this review is about income, not well-being.
People like being healthy, and so better health means better well-being even if the improvement in health does not increase income at all. Second, the review is not a bibliography on this topic.
Instead, I discuss and critique examples of work that I group together by mechanism and methodology. Third, the topic of this review is economics, not biology. There are many fascinating detours into biological mechanisms that I could take, but the focus is instead on economic outcomes, viewed through the lens of economics. Fourth, this review considers the response of income to a given im-provement in health, but not how to optimally design health programs. These features hopefully make this article more complement than substitute to existing reviews in this area.
Both theory and evidence suggest that we should stop thinking of health as a univariate object.
Health's impact on income likely depends on how health changes (morbidity versus mortality, for example) and when (childhood, working age, or old age). Health is multifaceted, and must be treated as such.
In Section 2, I consider effects of childhood health on adult income. Early-life health could depress human capital (broadly defined) and thereby reduce lifetime income. Even if a person is perfectly healthy as an adult, damage from childhood disease may be hard to undo. Most of a person's human-capital and physiological development happens early in life. Childhood is thus a key period for human-capital building, and the burden of disease in childhood could have effects that persist throughout the life course. There may also be shorter 'critical periods' during childhood, by virtue of which some aspect of human development is hampered if it does not take place at a particular, biologically determined age.
These ideas find confirmation in four strands of the literature, all of which estimate effects of some aspect of childhood health (or input thereto) on adult outcomes. One line of this literature finds a large labor-market return to adult height, which is, to some degree, a proxy of early-life health. A second line looks at large shocks, such as famines and epidemics and shows that time in the womb is a critical period of sorts. A third set of studies shows that nutritional deprivation early in life can have long-term consequences. Finally, a group of papers examines the effect of early-life exposure to tropical diseases. But caution is indicated if applying many of these results to the question at hand, in that various studies examine a rapid shock interacted with a narrow age window, which would have different consequences than a persistent change in health.
Taking a step back, I discuss the economics of how childhood health should affect adult income.
I use a simple model of human capital to integrate the variety of outcome variables used in this literature. A useful point of departure is the optimal choice of years of schooling in the standard model: a child should attend school until the marginal benefit equals the marginal cost. Childhood health plausibly affects both benefits and costs of schooling, so the model implies that the impact of childhood health on education is actually ambiguous. It is therefore difficult to interpret studies that use time in school as the only outcome.
Thinking about health and human capital in these terms leads us to the 'Envelope Theorem'.
This theorem implies that improvements in health affect income by making human capital more productive, but not via more investment. This means that lifetime income would rise because child-hood health allows you learn faster and grow up stronger. Health might also increase investments such as staying in school longer, but the discounted change in lifetime income from such investment is close zero if the marginal benefits and costs of schooling were already being equated. This analysis also affects how we evaluate evidence of complementarity across inputs to human capital, such as if early-life interventions spur later investments. The Envelope Theorem suggests that we should measure the direct effect of the intervention; whether the other inputs are substitutes or complements is of second-order importance. (This argument should be familiar to macroeconomists; it is analogous to the idea that gains in income per capita come from total-factor productivity, not from marginal changes in factors of production.)
In Section 3, I discuss the effect of adult health on adult productivity, via two distinct channels.
The first channel is the direct one: being sick today reduces your ability to work today. One approach is to measure the time lost to well-defined episodes of sickness and disability. On the other hand, we know less about more subtle effects of adult sickness on income, such as reducing the quality of the labor input via diseases whose symptoms are less episodic. A second channel is more forward looking: people invest more in childhood if their human capital will not be idled by disease in adulthood. However, this channel is of second-order importance, by the same logic as above: changing inputs that were already optimized has no effect, to a first approximation, on income.
Next, I explore the macro implications of the estimates from the micro literature in Section 4.
As a point of departure, I discuss in Section 4.1 attempts to extrapolate from micro estimate to the cross-country gaps. Calculations suggest that improving health in poor countries would raise income, but these estimates range from a few percent to tens of percent, depending on whether the intervention studied and whether a narrow or broad measure of health was used. By these extrapolations, improving health would deliver large increases in income to unhealthy regions, although the gap between rich and poor countries is one or two orders of magnitude greater than the gains estimated from the microdata.
Incorporating the response of population, which is affected mechanically by mortality, can alter some of these results, however. Reductions in mortality brought about the majority of the increase in population in the past two centuries (Preston, 1980) . Nevertheless, while lower mortality moves population onto a new growth path, where this path eventually settles depends on how fertility adjusts to the change in health. In Section 4.2, I interpret some recent studies within the quantity/quality framework, but argue that more research on fertility is needed. Then, tying these threads together in Section 4.3, I analyze changes in human capital and population. First, I review several calibration exercises. A starting point for this exercise is to recognize that (i) mortality restrains population growth and (ii) an increase in population dilutes the per-capita supply of nonlabor factors. Several studies argue that this combination can substantially attenuate-possibly even reverse-gains in income that might otherwise come from increases in human capital. This suggests that the 'Spectre of Malthus' continues today. But results based on sharply diminishing returns to labor, which are in a sense calibrated from the 20th century, may be less likely in the 21st. This is because of two large changes: urbanization and globalization, both of which make the economy less dependent on the amount of land that is locally available. I then discuss a few other issues in extrapolating from partial to general equilibrium.
In Section 5.1, I discuss evidence from cross-country comparisons in macroeconomic data. A large literature examines the relation between GDP per capita and proxies of health in a crosssection or panel of countries. The main finding is essentially the stylized fact that motivated this review in the first place. These studies are typically well done, given the methodological constraints.
But the constraints are non-trivial: it is difficult to know what to make of the causality between these two variables, and the use of a single proxy variable for health muddles the policy relevance.
Another difficulty in interpreting cross-sectional estimates is that we do not know the mechanism or timing with which improving health affects output. A smaller literature, described in Section 5.2, treats the aggregate response to large health shocks. First, I discuss within-country evidence from two studies. Next, I turn to a recent paper by Acemoglu and Johnson (2007) who examine, in a cross-national panel, improvements in health technology in the 20th century. They find that decreases in mortality were followed by increases in population and concomitant decreases in GDP per capita. This suggests that returns to labor diminish rapidly, although it is hard to square this result with observed shares of labor in production.
I then discuss recent criticisms of this study. I also consider explanations for the different results of these three studies, but argue that more research of this sort is needed.
In Section 6, I offer conclusions from this review. Whether we think of many of the estimates below as large or small is, in some measure, a question of perspective. In my judgment, the existing micro literature does point to effects of (some types of) health on output that are modestly sized.
Note that I mean 'modest' from the point of view of a macro/development economist: the income gap between Zambia and Sweden, for example, is very large, and the micro estimates of health effects explain only a small fraction of this difference. But from the point of view of a micro/labor economist, some of these estimates are quite large. From a policy perspective, several of these interventions appear to be well worth pursuing.
EARLY-LIFE HEALTH AND HUMAN CAPITAL
Poor health in childhood might depress the formation of human capital. This is likely to be true for two reasons: (a) much of a person's physiological and cognitive development happens in childhood and (b) economic theory (e.g., the Ben-Porath model) shows that human-capital investments should be made early in life. Notionally, Early-life health =⇒ Return to human capital =⇒ Income, which could affect lifetime income both directly and through investments. In this section, I discuss selected evidence that has been offered for this proposition. I then argue that we should focus on the direct effect only, and use insights from a simple model to filter the findings in this literature.
Height as a Proxy for Health. One indicator of early-life health is height, and numerous studies find that positive returns to being taller in developing-country microdata. Savedoff and Schultz (2000) summarize these results. One example is by Ribero and Nuñez (2000) , who find that adult wages rise 7%-8% per centimeter of height in Colombia. To address omitted variable problems, they use local resources in childhood as an instrument for adult height. Whether these instruments are valid is debatable: local spending on health early in life is probably correlated with a slew of other neighborhood and parental factors. In any case, there remains the issue of how to interpret the results. Does the return to height represent the effect of childhood health on the returns to human-capital investment, the direct benefit of being more physically robust as an adult, perhaps labor-market discrimination, or some other channel?
Critical Periods. Beyond the general importance of childhood as the base of human-capital formation, there are narrower windows that are critical for particular aspects of human development.
If this development does not occur within this window, perhaps because of some input that is missing, then the individual will have cognitive or physical deficits as an adult. 1 Notionally, we can represent an individual's adult human capital as h(x 1 , x 2 ), where the x t are inputs in each time period t, and the t = 1, 2 are two periods of development. Formally, then, t = 1 is a critical period 1 There is abundant experimental evidence of critical periods in development for non-human animals. A few examples suffice: (a) mice deprived of nutrition at various points in their development exhibit a host of physiological and cognitive deficits down the road; (b) monkeys that are deprived of nurturing in the first weeks of life develop behavioral problems later on; and (c) birds that are not exposed to their species' bird song during a particular window are never able to produce complex patterned song as adults. This highlights the possibility that, for humans, there might be periods in which the formation of human capital (including cognition, education, socialization, and language) is particularly sensitive to the presence or absence of certain inputs.
if h 1 h 2 , and even more so if h 2 ≈ 0. The key is not just that t = 1 is important, but also that there are no close substitutes-it is 'now or never'.
In the Womb
This section discusses evidence that the time in the womb is a critical period. A developing fetus grows, in percentage terms, at a phenomenal rate. Moreover, during the time in the womb, all of the major organs are grown from scratch.
The 'grand-daddy' of this area of research is the Dutch famine study. Towards the end of World War II, food rations were in very short supply in the Netherlands. The resulting 'hunger winter' of 1945 ended abruptly with the Allied liberation of that country. Followups found negative impacts of being in the womb during the famine on childhood growth, but minimal effects on IQ in adulthood, for example. (See Stein, Susser, Saenger, and Marolla, 1975.) Beyond just these specific results, the Dutch famine study also provides a guide to identifying in-utero effects. Namely, if a shock is large and sharply timed, then only a narrow band of cohorts would be exposed to it while in the womb. One can assess retrospectively whether the time inutero is particularly sensitive to the shock by analyzing outcomes across cohorts. The most affected cohorts should be visible as a 'blip' when graphing the sensitive outcome.
In recent years, other scholars have followed this model and found further evidence that the time in the womb is a sensitive period. I discuss a few here. Almond (2006) examines the 1918 influenza pandemic in a range of US datasets and finds that those born in 1919 (and therefore in the womb when the pandemic hit the US) had 2% lower income (among men) and 0.15 fewer years of schooling (both men and women). Almond and Maszunder (2008) show long-term effects on education for children in the womb during the periods of daytime fasting in the Islamic calendar. Meng and Qian (2006) find lower schooling for those born during the Great Famine in China. For the purposes of this review, results in this literature are nevertheless hard to interpret because of (i) their tendency to focus on education and (ii) the lack of comparability between these shocks and the baseline level of poor health and nutrition in poor countries. (I flesh out these ideas below in Sections 2.4 and 4.1, respectively.) Several other studies examine variations in weather conditions around the time of birth. Barreca (2007) show that cohorts born in warmer and wetter years in the US South (circa 1910) had lower education, which he attributes to malaria. Maccini and Yang (2009) find effects of unusual amounts of rainfall during the year before birth on education and household income among women (but not men) in Indonesia.
Perhaps prematurely, the in-utero story seems to have become a de facto standard for identification of the human-capital effects of shocks. There is no reason why the time in utero would be the only sensitive period. For example, Glewwe and King (2001) analyze a famine in the Philipines, and find the greatest effect on two-year-old children. In addition, a study that uses a short-duration shock might not detect a longer critical period at all.
A different angle on the in utero question is the study of birthweight, especially among twins.
For example, Behrman and Rosenzweig (2004) compare outcomes within monozygotic ("identical") female twins born in Minnesota. Comparing within identical twins removes family, genetic and temporal confounds, and they argue that differences in birthweight within the twin-pair arise because of random differences in nutrient intakes, perhaps due to different positions in utero. They find that, within the twin pair, the twin with higher birthweight had higher educational attainment and income as an adult. The external validity of this study is nevertheless open to question: are the returns to birthweight between twins the same as the returns to birthweight among singleton births? The relationship between birthweight and later-life outcomes is evidently a reduced-form one. But twin development in utero may be different enough from the maturation of singletons that birthweight no longer indicates the same thing.
Nutrition
Early-life health might also affect adult productivity because of nutrition, which has been studied in several interventions. (The results from famines in the previous section also were very likely about nutrition as well.)
A leading example of a nutritional intervention is the INCAP trial in Guatemala. The treatments were given to children in four Guatemalan villages four decades ago, so it has been possible to conduct a long-term followup on their effects. (Behrman, 2009 , provides a compact review of the long-term followup.) The villages were split into two groups and assigned one of two nutritional supplements: "atole" and "fresco", which were available daily to children during the trial. The atole supplement contained more protein and sugars; both had micronutrient supplements.
Results from the INCAP trial suggest quite large effects of early-childhood nutrition on adult human-capital outcomes. The findings in this paragraph refer to children exposed to atole instead of fresco in the first few years of life, using the atole-fresco difference among children exposed at older ages as a control. Male children who received the extra nutrition went on to earn wages that were one third higher than would otherwise be expected. Female children who received atole in the first few years of life attained over a year more of school. Both genders saw increases in various aptitude-test scores from the extra nutrition.
Nevertheless, a few issues with the design of the INCAP trial complicate the interpretation of these results. First, the atole was evidently more palatable than fresco, as the take-up was substantially higher. It is therefore hard to know whether the mechanism was more protein, or just more calories and/or micronutrients. Second, one of the control villages was drawn from a different region, and whether it represents an adequate counterfactual for the cross-cohort difference is debatable. Third, the fact that the sample is comprised of only four villages is problematic.
Two control villages are probably not enough to get an estimate of the variance in cross-cohort outcomes, which is needed to make valid inferences about whether the changes across cohorts observed in the treatment villages were unusually large. Because these effects are so large, and the policy relevance so clear, it would be useful to obtain further confirmation of this specific result for nutrition supplementation and income, perhaps in a well-designed retrospective study using the rollout of nutrition supplements that followed on the heels of the INCAP trial.
The importance of iodine in human-capital development has been extensively studied. The iodization of salt is very inexpensive, and so should be regarded as an easy intervention. Iodine deficiency has been related to mental retardation and intelligence in observational studies. Further, a meta-analysis (DeLange and West, 2003) of several interventions finds that remedying iodine deficiency early in utero raises the child's IQ by 5 points, or one half of a standard deviation. 2
None of these studies has results for adult income, however.
Tropical Parasites
The childhood morbidity coming from infection by tropical parasites may substantially depress human capital and subsequent income. I focus mostly on malaria and hookworm, parasites that are generally found in tropical regions. Both diseases have potentially severe chronic symptoms, notably anemia. Malaria, whose acute symptoms include fever, headache, and nausea, can result in death, but the case-fatality rate is actually low, especially among the strains predominant outside of subsaharan Africa. Hookworm is rarely fatal. Among children, hookworm and malaria have been associated with stunting of physical and cognitive development. It is not a leap to imagine that this reduces the return to human-capital investment. While age brings partial immunity, the damage from childhood exposure to these parasites may be hard to undo.
Research into the human-capital consequences of parasite infection during childhood falls into two broad categories: observational and experimental. Each type of research has its own advantages, but the two groups are, generally speaking, complements rather than susbtitutes. Experimental studies allow us to be well assured of the causality, but are typically limited to the short term.
Observational studies, on the other hand, can consider longer term outcomes if they are based on the retrospective analysis of health conditions. Thus many of the observational studies that I review here consider eradication campaigns that took place some time ago.
While one can never rule out that results from an observational study are driven by some unmodeled factor, the commonalities across the campaigns studied in the literature suggest a 'recipe' for identification. First, these campaigns brought about large and sudden changes in the disease environment. Second, the countries considered have (a) less-infected areas that can serve as a comparison group, and (b) microdata available that cover the relevant sets of cohorts. And third, these campaigns began because of critical advances in health technology and spending that originated outside the affected regions, which should mitigate concerns about reverse causality.
One example of this line of research is a study (Bleakley, 2007a) in which I analyzed the impact of a hookworm-eradication campaign in the southern US, where in 1910 children had infection rates of 30%-40%. Children growing up in areas that benefitted from the anti-hookworm campaign saw large increases in literacy, school attendance, and income, relative to earlier cohorts. The changes in these outcomes coincide with childhood exposure to the eradication efforts, which further suggests that we are measuring the effect of deworming rather than some regional trend. According to my estimates, childhood exposure to hookworm depressed adult income significantly in the South.
Instrumental-variables estimates of the effect of hookworm on income can be interpreted as follows:
If I take your point-in-time probability of hookworm infection in childhood from zero to one, it reduces your adult income by 43%. (Note that this refers to persistent infection, not to having ever been infected.) Eradication would therefore imply a long-run human-capital gain of 17% in the American South.
Experimental studies also find positive impacts of deworming on human capital, albeit at shorter horizons. Two examples are Miguel and Kremer (2004) and Bobonis, Miguel, and Sharma (2006) .
Both papers find that intestinal worms reduce school attendance. Miguel and Kremer did not, however, obtain strong results for achievement tests. Another feature of the Miguel/Kremer paper is the assignment of treatment at both the individual and school level. Disease transmission from control to treatment group will tend to reduce treatment/control differences, which they show.
(They interpret some of their effect on attendance as working through non-health spillovers, although it is possible that measurement or specification error on the health side could generate something resembling a non-health spillover.)
In another study (Bleakley, 2007b) , I estimate the effect of one's childhood exposure to malaria on income later in adulthood. I analyze malaria-eradication campaigns in the United States (circa 1920), and in Brazil, Colombia and Mexico (circa 1955) . The basic finding of the study is that cohorts born after eradication had higher income and literacy as adults than the preceding generation, relative to cohorts from non-malarious areas. The change across cohorts coincides with childhood exposure to the campaigns. The magnitude of the change in income associated with childhood malaria is substantial. Reduced-form effects on income, when comparing the least malarious to the most malarious areas within a country, are on the range of 12% (in the U.S.) to 40% (in Latin America). Although it is impossible to completely rule out that the intervention had effects through channels besides estimated malaria infection, the results that suggest that persistent childhood malaria infection reduces adult income around 50%. The normalized effects are similar across the four countries.
Two other papers find that childhood exposure to malaria-eradication campaigns had impacts on human capital. Lucas (2009) 
The Role of Schooling, and the Envelope Theorem
The outcome variables above were a mix of income and education. How do we combine these results into a coherent whole? Recall that years of schooling is an input to the production of human capital; it is not synonymous with human capital itself. This fact affects the interpretation of the literature above.
Consider a textbook model in which the individual chooses time spent in school so as to max-imize lifetime income. Let the benefits of schooling be b(e, h) and the costs be c(e, h), where e is years of education 3 and h is health (thought of here as lower childhood morbidity or better developed cognition). The benefits b include the appropriately discounted sum of future earnings. The costs c are both direct and opportunity costs of schooling. The usual assumptions 4 are that the marginal benefit of schooling declines with more time in school, but that the marginal cost rises: c ee > 0 and b ee < 0, where subscripts denote partial derivatives.
A child should stay in school as long at the marginal benefit exceeds the marginal cost. At an interior solution for schooling he will equate marginal benefits and marginal costs, b e = c e , which maximizes lifetime income with respect to years of schooling. If you are even close to the optimum, marginal benefit is still pretty close to marginal cost, and you are pretty much indifferent between attending and dropping out. Thus, compelling, tricking, or bribing people to spend more years in school takes effect when the net gains from schooling have been largely exhausted. 5 (Numerous fashionable policy initiatives, such as conditional cash transfers, do this to some extent.)
Perhaps counterintuitively, the effect of childhood morbidity on years of schooling is actually ambiguous. The optimal response of schooling to health becomes
By assumption, the numerator is negative. The working assumption of the literature review above is that childhood health increases the marginal benefit of schooling: b eh > 0. But it is probably also the case that c eh > 0: a healthier child can earn more in the labor market. This term makes the denominator of ambiguous sign. In words, reducing childhood morbidity raises years of education if and only if childhood morbidity depresses the marginal benefits of education more than it reduces the marginal costs (including opportunity costs, such as foregone wages). This result is true regardless of the sign of b h .
With this simple and entirely standard model, we see that years of schooling (e) is not a sufficient statistic for measuring the impact of early-life health on lifetime income. It is possible that when health improves, lifetime income goes up, but years of school declines. All that needs to happen is that being a healthy kid raises the wage more than the returns to the schooling. Indeed, any combination of sign( de * dh ) and sign(b h ) is possible. Herein lies the problem for using education as a sufficient statistic. Yet, many of the studies reviewed above measured responses of years of schooling, but not income. 6
At this point, some readers might question if schooling being chosen to optimize income is a good assumption, although this does not rescue the view that years of schooling is the central outcome. First, perhaps people maximize lifetime utility rather than lifetime income. Fine, so the analysis above is only about welfare. Second, some would argue that the rise in opportunity cost from improved health is low because of unemployment, but note that unemployment also reduces the marginal benefit of schooling is reduced. Third, suppose that there is some constraint that prevents children from going to school: for example, a credit-market imperfection. In this case, while more education would increase lifetime income, we do not know whether improving childhood health would unambiguously predict going to school more. It seems as likely that health increases the opportunity cost without resolving the problem in the credit market.
Next, the quantity of schooling is not an important channel through which childhood health impacts income. The reason, simply stated, is the Envelope Theorem. Consider the individual's discounted lifetime income, y, at the optimal choice of schooling: y * ≡ y(e * , h), where e is years of education and h is health (thought of here as less morbidity in childhood). This will respond to health via two channels, as seen by taking the full derivative of y * w.r.t. h:
The first term values the increase in years of schooling ( de * dh ) at the marginal return to schooling ( ∂y ∂e e * ). But notice that the marginal return to schooling (for lifetime income) is zero at the optimal choice of schooling. So, changes in the quantity of education are not of first-order importance. 7
This result seems at odds with the way education treated in some empirical microeconomic research. In my experience, education is often presumed to be a central channel between early-life events and income. Indeed, it seems to be used as a plausibility check by some, such that a result for income cannot be correct if it is not 'explained' in large measure by years of schooling. This is ironic, because instead of it being a plausibility check, it is instead an irrelevancy check. Limiting ourselves to studies of health and income in which education is the main mechanism is a recipe for minimizing our estimates of the effect of health.
These results matter for the interpretation of the studies reviewed above. In the interest of evenhandedness, let me pick on some of my own research first. One of the better documented critical periods from psychology is associated with language acquisition. In Bleakley and Chin (2004) , we examine childhood immigrants to the US who arrive before and after this critical window, and use migrants from English-speaking countries as a comparison group. We find that arriving after the critical period earn as much as 15% lower wages as adults, and attend 1.5 fewer years of school.
One approach would be to say that this is an enormous effect of language because we found a large increase in earnings and in schooling. But those extra years in school were not free; they were instead purchases by not working during that time. At rates of return to schooling for that sample, the increase in schooling was only slightly more than compensated by the increase in wages later on. It makes a big difference whether we are talking about an effect on income that is 15% (the unadjusted) or an effect that is closer to 2% (adjusted for schooling).
How does this insight apply to the literature on health and human capital above? First, all of the literature above whose only outcome variable was years of school are, by the envelope logic, measuring changes that are not of first-order importance to lifetime income. Next, consider some examples that treat both education and income. On the one hand, Almond (2006) measures decreases in earnings around 2% for men born in 1919, but at least half of this is due to having spent less time in school. Indeed, for a borrowing interest rate of 13% or more, the 1919-born men actually had higher lifetime income. Among women, Almond estimates that being born in 1919 reduced education, but with no concomitant effect on earnings. While it is difficult to estimate the returns to schooling if much of that sample was in home production, spending more time in school and getting no return in the labor market (ceteris paribus) can hardly be viewed as a good thing that the women born in 1919 missed out on. (Both genders suffered from more health trouble if they were born in 1919, which I presume reduced their utility. None of the preceding analysis is meant to minimize this.) On the other hand, Maccini and Yang (2009) find increases in income proxies for women in Indonesia who were born after favorable weather conditions, and they argue that these results are entirely explained by increases in education. Filtering their results through the standard theory of schooling suggests no sensitivity at all of lifetime income to early-life rainfall.
So how might childhood health increase human capital and, thereby, income? The model provides further insight. The second term of equation 1 measures the direct effect of health on labor productivity, evaluated at e * . It is instructive to decompose this direct effect into two parts:
The first part is the effect of health on income for those with no education (e = 0), while the second part is the changing returns to inframarginal schooling investments. These latter terms point to first-order benefits of health by raising the inframarginal return to education. In words, childhood health can raise the quality of education received (children can learn better, e.g.), and this can produce an increase in income of first-order importance.
Several studies reviewed above provide examples of improved health increasing income, but not principally via marginal years of schooling. In the INCAP trial (Behrman, 2009) , males exposed to the extra nutrition during their first three years experienced large increases in income, but very little change in time in school. Estimates from the campaigns against tropical disease (Bleakley; , 2007a Cutler et al, 2009 ) also illustrate the problem with using the quantity of education as the chief channel of childhood-morbidity effects on income. In no case does schooling account for more than a quarter of the effect of productivity. Indeed, in one case (Mexico), adult income rises with less childhood exposure to malaria, but years of school actually decrease.
Beside measuring the effect on income with income data, how else can we detect first-order effects of childhood health on income? Outputs like literacy and achievement/IQ tests seem like good measures as well, although the eventual benefit from acquiring such skills would need to be measured and weighed against the extra time in school (if any) that was required to learn them. One can also look at the intensive margin: more frequent attendance 8 or school progression, for example. Especially for young ages, these measures are clearly inframarginal; an example is Bobonis, Miguel, and Sharma (2006) who analyze anemia and pre-school attendance. is clearly a good thing in isolation, but we should take stock of the phenomena that we ignore as a result. In this case, if you want to identify an effect that has a longer window of sensitivity or with a shock that is less compactly timed, you might be out of luck. In my own work on tropical disease, I attempt to measure the effects of exposure during all of childhood using campaigns that took effect over five or more years, but it required a combination of long spans of data (75+ years of cohorts) and diseases that likely had large impacts, a 'perfect storm' that might not be repeated for other questions.
Critical Thoughts on Critical Periods
When thinking about how much poor health impedes development, we should contemplate a large and persistent reduction in disease. But-however well identified-short-term variation in
[insert disease here] is likely to have economic impacts that differ from those due to long-term changes. In terms of the model of critical periods above, a blip-blip design measures the differential effect of early exposure, or h 1 − h 2 , but for the question that motivates this review, we want to know the level of both h 1 and h 2 .
The Earlier, The Better? A recent theme in policy circles has been the importance of intervening early in childhood. The above discussion on critical periods would seem to substantiate this. But we should exercise caution in interpreting sensitivity to early inputs as evidence of critical periods, or even as evidence that early intervention is warranted.
Here I present a model that exhibits excess early sensitivity, but does not have a critical period, nor are the correctly measured returns to early intervention actually higher. I return to the model of a critical period shown above, but strip out the features that yielded a critical period. Lifetime income is h(x 1 , x 2 ), where the x t are investments made in periods t = 1, 2, corresponding to early and late childhood. Suppose that for any x 1 = x 2 , the marginal products are the same for each x;
that is, h 1 = h 2 , where subscripts on the h refer to partial derivative w.r.t. the numbered argument.
This implies that there is no critical period in x. Suppose further that the x are complements, 9 so that h 12 > 0.
What are the returns to exogenous changes in the inputs in this model? Suppose that the additional input was unanticipated, as would likely be the case in trial intervention. The response to additional input in period 2 is dh dx 2 = h 2 , while the response to additional input in period 1 is
. Because the decision about x 2 is made after x 1 , the optimal x 2 can incorporate the new information about x 1 , while the opposite is not the case. The x are complements, so
. The response to earlier inputs is larger than for later inputs,
9 Cunha and Heckman (2008) refer to this sort of complementarity as "dynamic complementarity".
because you can invest more in period 2 in response to the intervention in period 1.
What empirical findings would come from a study of interventions in x 1 or x 2 ? If the x t are chosen to maximize lifetime income h, then h t = c, for t = 1, 2 and c being the unit cost of the inputs x t . It follows that dh dx 2 = c and dh
In words, the increase in lifetime income is greater if the child is given a little extra input in period 1 instead of period 2. Perhaps the researcher who obtains this result would stop here, but is this really evidence that 'the earlier, the better?' No, because the increases in input costs exactly match the increases in income. (I could go through the case in which x 2 is a time input like years of schooling, and-even worse-if the researcher used x 2 as the main dependent variable instead of income, but this is treated above.)
A remaining concern with this analysis, however, is that early-life investments might be chosen suboptimally, perhaps by parents who do not fully account for their children's welfare in their decisions. Inputs to human capital might not be set optimally, but this issue cannot be resolved by demonstrating complementarity with other inputs. Instead, what is required is a comparison of gross returns (the dh dxt ) with an accounting of all associated costs, including those downstream. 10 While the conventional wisdom among economists is that 'crowd out' is bad, this does not imply that 'crowd in' is a free lunch. The resources that are 'crowded in' themselves have opportunity costs, and again the Envelope Theorem is relevant.
The insights from the model above should guide our interpretation of observational studies as well. An amusing example is the much discussed Stanford Marshmallow Experiment (Shoda, Mischel, and Peake, 1990) . In that study, young children are asked to refrain for 15 minutes from eating a marshmallow that had been placed temptingly in front of them, and the prize for waiting was a second marshmallow. The children who were able to delay gratification were also found to score significantly better on standardized tests a decade later. No doubt they will do better in the labor market as well. But is there a large return to this skill? Perhaps, although presumably much of the later increase in human capital comes from working hard, which is not without cost.
Empirically, whether we can measure the fundamental return to such skills depends on whether we can cost out their correlated investments.
ADULT HEALTH AND INCOME
Adult health might also affect income, through two human-capital channels.
1. Adult health =⇒ Income. That is to say: directly. This is most easily understood as illness today reducing the ability to work today.
2. Adult health =⇒ Return to human capital =⇒ Income. The return here, unlike above, is like a lower depreciation rate: the utilization rate of human capital can be higher if it spends less time idled because of disease. If this is expected, early-life investments in human capital should increase.
Contemporaneous Effects of Health on Income
Perhaps the most obvious channel through which health reduces income is that you work less when you are sick. But the pertinent question is by how much. Researchers have addressed this question with several strategies.
The first approach for measuring the magnitude of this channel is by accounting for lost output during episodes of acute sickness. It is understandable that researchers would focus on acute episodes because (i) the causality is clear, at least in the Granger sense, and (ii) acute stuff is what medical people focus on. However, not all diseases can be well characterized simply as a sharply defined episode of acute morbidity. Ashraf, Lester, and Weil (2009) provide a thorough accounting of these effects across a broad set of diseases. Relative to rich countries, the additional labor input lost to well identified episodes of sickness in poor countries is non-trivial, but not a number large enough to close much of the gap between these two groups. At some level, this fact should not be surprising. Swedish people work, if anything, less over the life cycle than Swazilanders, in spite of Sweden being less disease ridden.
A second approach consists of observational and intervention studies-that is, either in a crosssection or in a panel following up on treatment-of income and specific diseases. An early example is by Schapiro (1919) , who examines the productivity increases among plantation laborers in Costa Rica following deworming treatments. Almost all of the workers were found to be infected with hookworm, compared with approximately 10% after treatment. He found that productivity six months after treatment was 15%-30% higher, and the area cultivated had expanded by 50% the following year. Weisbrod et al. (1973) , on the other hand, found small effects of various parasitic diseases on earnings in a cross section of laborers on Saint Lucia. (The case of plantations is noteworthy: large land-owners might have better incentives than individual farmer to manage the transmission of such diseases.) A third method is the experimental evaluation of treatments for specific diseases. A leading example in this vein is by Thomas et al. (2003) , who conduct a randomized trial of iron supplements in Indonesia. They find increases in contemporaneous adult productivity, and argue that the main mechanism is the reduction of anemia. A feature of this study relative to earlier work is that it follows up individuals rather than basing the sample on particular workplace, where selection effects could bias results and where returns to health might be muted if occupational choice is limited.
Adult Health and the Return to Schooling
A decrease in working-age mortality extends the horizon over which human-capital investments can be utilized. Recall the model above, but now think of h as adult life expectancy. A decline in mortality means the asset called 'human capital' now depreciates more slowly, which increases the benefit of going to school: b h > 0. Even with schooling held fixed, this generates a first-order gain:
people can spend more time working because they do not die as quickly. This has nothing to do with education; it is simply a change in expected value stemming from the change in discounting.
Nevertheless, the reduction in working-age mortality gives people the incentive to spend more time in school, unambiguously. Unlike the change in h above, the reduction in adult mortality should not affect the opportunity cost of going to school as a child, so c h = 0 and therefore c eh = 0. By standard assumptions,
However, the relevance of this theoretical result for education has been the subject of debate. Preston (1980) argues that this effect is small relative to secular increases in education. In contrast, Kalemli-Ozcan, Ryder, and Weil (2000) present a calibrated model arguing that time in school should respond to a larger degree. Nevertheless, Hazan (2006) shows that, historically, while adult life expectancy has risen in developed countries, hours worked have actually declined, and thus the effective discount rate that should be applied to human-capital investments has gone in the opposite direction from the horizon story. On the other hand, Jayachandran and Lleras Muney This debate notwithstanding, this mechanism is not of first-order importance for income in a standard model. Higher schooling delivers a marginal benefit in the form of higher wages in the future, but comes at the cost of spending less time working early in life. Evaluated near the old optimum, this marginal benefit is still very close to the marginal cost. The horizon channel of education is therefore of second-order importance for lifetime income. (In Harbergerian terms, the benefit of more education here is a triangle rather than a rectangle.) The action for expected income works through the change in health, not through the resulting changes in inputs. Readers will recognize the Envelope Theorem at work, yet again.
GOING FROM MICRO TO MACRO

Extrapolation
The results above suggest that health conditions can affect productivity. But how do they help us gauge health's contribution to the gap between rich and poor regions? To begin, consider an extrapolation of the following form: Combining estimates from well-identified micro studies with survey data on health, we should have the ingredients necessary to make this calculation. Readers may balk at this exercise as it is a somewhat wild-eyed extrapolation. Granted, but the point of the exercise is to define an order of magnitude, not an exact number.
One approach would be to measure the effect of health on years of schooling and extrapolate from there, multiplying by standard returns to schooling. This would be wrong, for reasons that were detailed in section 2.4. Again, if education is chosen close to optimally, the first-order effect of increasing education on lifetime income is much smaller than the Mincerian return. Instead, we need to measure the impact of health on income somehow, otherwise we are missing that first term in the equation above.
Income was indeed an outcome variable for a few studies related to epidemics or famines, but this is not enough to start extrapolating. The basic problem is that we do not know how to normalize these results into units that are informative about the gap between poor and rich regions. An example might clarify this issue: consider a cohort born in a rich country, but in a year with some bad shock. By analogy, the cohort most exposed to the bad health shock is like someone born in a poor country's health environment. But is this shock like the environment in poor countries by a lot or just a little? We do not know, and so we cannot use these results to extrapolate. Instead, we need to consider types of health that are reasonably well defined and arguably comparable across place and time, otherwise we are missing that second term in the equation above.
A notable attempt at such an extrapolation for a broad measure of health is by Weil (2007) .
Weil uses some of the micro studies on returns to height (cited above) as a benchmark. Because of data problems, however, he has to relate these results to the cross-country question by translating the units from height into life expectancy, by way of the adult survival ratio. The two additional reduced-form 'translation' terms in Weil's calculation add error to the extrapolation, but this exercise might still be useful for obtaining an order-of-magnitude estimate.
The results from Weil's extrapolation suggest a large, though not pre-dominant role for health.
In terms of the variance in output per capita across countries, health explains a fraction that is comparably sized to what is explained by either physical or human capital. Further, these three factors combined explain a narrow majority of the variance in output per capita across countries.
Nevertheless, a substantial minority of the variance is still unexplained by measured factors.
An alternative way to extrapolate from the micro evidence is to consider narrower measures of health, rather than attempting the calculation for general measure of health. If the measure of health is tightly defined, it might be easier to translate estimates from one context to another, and thereby avoid the 'units' problems in Weil's exercise. But this has the disadvantage that the measure of health is not a comprehensive one.
An example of this approach is by Behrman and Rosenzweig (2004) , who extrapolate their estimates of the effects of birthweight to cross-national data. In their study, they use withintwins differences in birthweight and adult income from a sample in Minnesota. They report, using their within-twin estimates, that birthweight differences explain around 1% of the variance in output/capita across countries. (However, about one third of their estimates for income worked through years of schooling, which suggests that their extrapolation should be a third lower.) On the other hand, in a bivariate regression on cross-national data, average birthweight explains around 45% of the variance in GDP/capita. These two results suggest that most of the birthweight/income relationship across countries is due to reverse causality and omitted third factors, rather than the causal effect of health. However, their within-twin estimates from Minnesota may not extrapolate well to poor countries, and this depends on the relative size of selection and scarring effects across 
Whither Population?
A potentially large effect of improving health is to change the size and composition of the population.
Increases in population come from people not dying as quickly as before, and from changes in fertility and fecundity that follow improvements in health. Preston (1980, pp315-16) states that "the vast majority of the acceleration in world population growth during the 20th century is attributable to mortality decline rather than to a rise in fertility." Nevertheless, the eventual deceleration is due to fertility, and the magnitude of the shift from the previous baseline for population depends on how fertility adjusts.
Unfortunately, our understanding of fertility's adjustment to large changes in health (among other things) leaves something to be desired. One common approach in demography is to allow for an ad hoc, mechanical adjustment of fertility to a rate that stabilizes population growth at the previous level, but this seems a poor description of the data (Preston, 1980) . Furthermore, even within this framework, the long-run change in population depends crucially on the speed of fertility adjustment (Ashraf, Lester, and Weil, 2009 ). The demographic transition (or lack thereof) is marked by substantial heterogeneity, both historically in the developed world and in recent generations in less-developed countries. This highlights the complicated nature of the comovement between health and fertility.
The contribution of economics is often to introduce prices into thinking about human behavior, and fertility is hopefully a good example of this. Consider the standard quantity-quality (q 2 ) model, which has two features. First, think of child rearing as having distinct two outputs: the number of children (quantity, or n) and the average human capital of children (quality, or q). Parents will demand quantity and quality according to their prices: p n and p q , respectively. Second, by some mechanism (perhaps the budget constraint), quantity and quality are substitutes. The first point finds confirmation several recent empirical studies of fertility. Acemoglu and Johnson (2007) examine the large declines in mortality (especially infant mortality, so p n ↓) that took place circa 1950, and find large, positive responses in birth rates. When analyzing declines in maternal mortality (p n ↓) in Sri Lanka, Jayachandran and Lleras Muney (2009) find an increase in fertility.
But does fertility respond to p q ? Fabian Lange and I (Bleakley and Lange, 2009 ) examine hookworm eradication in the southern US. This change reduced p q in that it was now easier to rear an educated child, while p n was essentially unaffected because the disease was rarely lethal. Fertility declines with the reduction in hookworm, which is consistent with the q 2 model. 11 Recent work on malaria fits in this framework, but suggests that a generational perspective is useful as well. Adrienne Lucas (2009) estimates fertility rates before, during, and after the malaria-eradication campaign (circa 1950) in Sri Lanka. Her results vary by generation. Women in their fertile years around the time of the campaign had higher fertility following the decline in malaria, but women in childhood at that time went on to have fertility rates comparable to those in the non-malarious parts of Sri Lanka. Both generations had a lower p n than previous cohorts, but the second generation, which had escaped exposure to malaria in childhood, also had higher human capital, and thus the opportunity cost of mom's time was higher. Whether or not the q 2 interpretation is right, however, these results are hard to square with a univariate model of health.
Beyond Partial Equilibrium
When the health environment changes, so does the size and composition of the population. These resulting shifts in quantities supplied should all change relative prices. Accordingly, we need to think in general equilibrium. Below, I discuss some work in this vein and highlight mechanisms to bear in mind when we go beyond partial equilibrium.
Calibration Exercises. Several studies consider the quantitative impact of health on output per capita in a calibrated, general-equilibrium framework. I discuss some examples here. Barlow (1967) considers the impact of malaria eradication, although that study does not consider the human-capital aspect quantitatively. Young (2005) gauges the effect of HIV/AIDS. A paper with a more comprehensive coverage of diseases is by Ashraf, Lester, and Weil (2009) , who use a standard neoclassical framework. They combine a demographically driven change in effective labor with 11 The relative magnitudes of quantity and quality responses estimated by Bleakley and Lange are similar to the aggregate comovements of these variables, which provides a quantitative confirmation of the model as well. However, studies using twin births, such as the seminal article by Rosenzweig and Wolpin (1980) , tend to find smaller responses of quality to quantity. (See also Angrist, Lavy, and Schlosser (2005 ), Black, Devereux, and Salvanes (2005 ), Caceres (2004 ), and Qian (2006 .) It is nevertheless an open question whether rationing parents away from their optimal fertility choice (by twinning, e.g.) identifies the relevant mechanism in the q 2 model. A preferred test of the model is to examine responses of q and n to changes in prices, which corresponds to the historical changes. Put differently, if the goal is to understand the historical experience, then we should understand that secular trends did not arise because parents were forced to have fewer children, so much as they adjusted their fertility decisions to changing prices. both a fixed factor and a slowly adjusting capital stock. They analyze a single-sector economy, and fertility is modeled as a partial adjustment to stable growth, as described above. All three studies present a fairly pessimistic view of the effect of health improvement on output per capita.
Central to these results is an assumption of diminishing returns to labor, which arise is some other productive factor, such as land, is in fixed supply.
The effects of land dilution can indeed be large in a model land-dependent economy. Consider an economy characterized by a constant-returns-to-scale (CRS) production function:
The inputs to h are capital (K), labor (L), and a fixed factor (F ). The reproducible factors, K and L, can adjust, while the fixed factor is assumed to be invariant. The response of income per capita to an increase in labor is, in elasticities, as follows:
The first term reflects the marginal product of labor. The second term comes from the marginal product of capital × how capital adjusts to the higher population. The third term is unity: income per capita declines mechanically when there are more capitas. Because the production function h While improving health means, in part, more population and more land dilution, this does not necessarily imply the return of Malthus in the 21st century. Some context is in order. What did the typical less-developed country look like 50 years ago versus today? The vast majority of its residents were in rural areas. Also, for most poor countries, this was the era of looking inwards as a growth strategy. Capital flows were sharply restricted, as was international trade. Migration to rich countries was also limited. All of these features accentuate the diminishing return to labor.
But does this seem like a typical developing country today? Not really, because of two changes: urbanization and globalization.
Urbanization. The developing world is much less dependent on land than it was a half century ago. If the working-age population rises by x%, does the average plot of land get x% more farmers?
Recent historical experience suggests not. As of a few years ago, the majority of the world's population lives in urban areas, continuing a long trend of migration to cities. Latin America, for example, went from 40% urban at mid-20th century to almost 80% today. Things today are less land-centered and more people-centered, with urbanization giving rise to agglomeration economies.
In other words, we expect increasing rather than decreasing returns to scale. In the long run, land is much less of a constraint, although congestion effects eventually kick in at much higher densities.
Globalization. The assumption of a closed economy seems increasingly unrealistic for the 21st century. How would openness change the results above? There are three mechanisms: capital flows, international trade, and migration. Allowing capital to flow across borders means that a country is not constrained by its own savings to finance investments. In sensitivity analysis, Ashraf, Lester, and Weil (2009) allow for capital to flow in from the outside world. This reduces capital dilution, and therefore output per capita falls less in the short run when population rises. Next, migration can act as a 'safety valve' when an area becomes overpopulated.
Openness to international trade should attenuate the effects of an expanding population on income per capita, if the economy is diversified in the right way. In the extreme, we would expect factor-price equalization. If so, labor income per capita is no longer dependent on the stock of population.
Nevertheless, there is one effect of population that is unavoidable: the dilution of land rents.
These rents can be especially large for extractive activities, where the rents literally flow from the ground. As Weil and Wilde (2009, page 258) observe, "it is hard to imagine that Nigeria's oil production would be substantially different if the country had half (or double) its current population." Thus doubling the population would simply halve oil revenue per capita.
Land Improvement. The threat of disease might deter land improvement. While we think of land as a 'fixed' factor, it is not in truly fixed (effective) supply in the sense that land can be improved. Malaria is often cited in this context. A leading example comes from the construction of the Panama Canal: the control of malaria on the isthmus was important for the successful completion of the canal by the United States, and conversely the failure of the French effort was partly due to a lack of scientific knowledge about malaria transmission at the time. Relatedly, malaria control in Nepal spurred migration and land improvement in the lowlands of Nepal, although the resurgence of that disease in the 1980s undid some of gains from earlier control efforts.
Compositional Changes. Beyond just population, health improvements will change the mix of ages and skills in the labor force. First, there is a direct effect of demographic composition on output: for example, by changing the fraction of the population that is of working age. But these demographic waves do not have permanent effects on the growth rate, absent some other structural change. Second, the changing composition of the population affects prices. Consider a few cases.
First, suppose the shock to health brings more human capital to an economy where skilled labor is very scarce. In this case, the response of output would be more positive than the fixed-price baseline. Suppose instead that the change in health did little but decrease mortality among infants in poor families. This would likely increase the supply of low-skilled labor in an economy that is already skill-scarce, and average income would rise less (or decline more) than expected.
Spillovers from Human Capital. External effects in production coming from human capital would complicate extrapolating from micro studies, which, by design, assume that the control group is not affected by the treatment variable. Measuring external effects, therefore, requires analyzing shocks at a higher level of aggregation (for example, the city or state) although there is no getting around the assumption that some area or group somewhere represents the counterfactual or control group. Additionally, there are considerable challenges to decomposing the causal external effect from correlations that arise from the sorting of factors across space. Moretti (2004) discusses the evidence of human-capital spillovers within US cities, mostly derived from cross-sectional and panel comparisons to estimate the effects. Acemoglu and Angrist (2000) use compulsory-schooling laws in the US as instruments for average education, and they find spillovers to income of 1%-2% per average year of schooling in one's state of residence, although they cannot rule out external effects of zero either. There are just a few studies directed at measuring external effects of human capital in developing countries. Conley, Flyer, and Tsiang (2003) use geo-coded data to analyze the spatial aspects of human-capital spillovers in Thailand, although the properties of spatial equilibrium might not be informative about how the whole country would respond to an increase in human capital. Duflo (2004) , on the other hand, analyzed the general-equilibrium impact of a school construction program in Indonesia. Duflo reports that the entrance of more educated cohorts appears to depress wages for incumbent, less educated cohorts. This suggests a negative spillover from human capital, at least at over some horizon. In sum, the evidence is mixed, at best, for large, positive external effects of education in production in developing economies.
Intergenerational effects. If having healthier parents raises the human capital of their children, the effects discussed above could be magnified. There is some evidence of intergenerational effects in the research mentioned above. 13 But how much does this add to the magnitude for income?
Take an intergenerational elasticity of income to be 0.3. Should we simply multiply all of these effects by 1.3 to get the impact on the next generation? Probably not. It is unlikely that 0.3 is causal, Furthermore, some of this transmission works through inputs that should be costed out, such as parents' time nurturing and children's time in school.
Morbidity versus Mortality. Not all improvements in health will increase population so automatically. For example, research on nutrition and parasitic disease find increases in productivity, but minor effects on mortality. This means that malnutrition and tropical parasites have their greatest effect, not by adding more warm bodies to the labor force, but by preventing their victims from achieving their full productive potential.
MACRO ESTIMATES
Cross-Country Evidence
I could fill up my allotted space with references to papers that include some measure of health in a cross-country growth regression. The predictive power of health variables is illustrated by Salai-Martin (1997) who reports which variables are most often statistically significant from literally millions of permutations. In this exercise, health variables (specifically life expectancy, malaria, and infant mortality) are among the most robust predictors of growth. (Note that this should not be thought of as meta-analysis in that the sample for each test is the same.) Nevertheless,
13 Females given fresco instead of atole in the INCAP trial or who were in the womb for the Dutch winter famine both had smaller babies many years later (Behrman, 2009; Stein et al 1975) . It bears mentioning that these are, if anything, level rather than growth effects of health. First, although economic growth is on the left-hand side of growth/convergence regressions, the usual interpretation of these coefficients is that health affects levels. 14 Second, the micro estimates and human-capital theory above are also consistent with a level effect, although it is hard to imagine estimating a growth effect in a micro study, because the comparison groups are in the same economy as thosed treated.
Nevertheless, improving health could generate a temporary spurt of growth during the transition to a new level. This is especially important if it is early-life health that affects adult income. For instance, if the improvement in health benefits mostly infants, then none of the labor force is affected in the immediate aftermath, and this fraction increases only slightly for twenty years after the shock. Indeed, it would take more than half a century to realize the full effect on income if the mechanism were via exposure in infancy.
A different set of studies relate economic output across countries to local malaria prevalence.
Because the outcome variable is output per capita, this is a more direct method of assessing the relation between health and output than the convergence regressions. Sachs (2003) reports that ln(GDP/capita) is lower by 1.3 as the fraction of the population potentially exposed to malaria goes from zero to one. Adjusted for differences in units, these estimates are about four times larger than the impact of persistent childhood exposure to malaria, even adjusting for general-equilibrium effects (Bleakley, 2006 and 2007b) . Bhattacharyya (2009) , on the other hand, finds that malaria is a robust determinant of output per capita in Africa data, and that controlling for malaria (or, indeed, climate) renders insignificant variables for institutional quality and the history of slave exports. An advantage of these studies is that they use the ecological conditions such as climate as an instrument for malaria, rather than the endogenous outcome of whether malaria has been eradicated. Nevertheless, while the ecology of malaria transmission is reasonably well modeled by local climate and geographic factors, it is an open question whether these factors affect economic activity only through malaria.
14 A growth/convergence regression predicts economic growth as a function of the initial level of output per capita and other pre-determined variables. If the estimated system is stable, it implies a 'target' level of output per capita to which the country converges eventually. The right-hand-side variables determine what this target level is.
A few studies consider, at the country level, outcomes besides income. Lorentzen, McMillan, and Wacziarg (2008) relate adult mortality to increases in risky behavior. Bloom, Canning, and Graham (2003) show that longer life expectancy is associated with a higher saving rate. Bhattacharyya (2009) finds that saving is higher in African countries with less malaria. Alsan, Bloom, and Canning (2006) show that healthier countries receive more foreign direct investment.
Even if the causality could be resolved in the cross-country estimates discussed above, there remain difficult questions of when and how. Disease ecologies are persistent, and so a crosssectional result does not clarify over what horizon health improvements would have their effects.
The micro evidence above suggests that the very short-run effect is small, but even the potentially larger human-capital effects are an order of magnitude smaller than the macro estimates. Capital and land-improvement effects would also take effect slowly. (But the arguments above about the envelope theorem apply just as well to changing investments in capital and land.) The mechanism also matters for interpreting the result and designing health policies. Perhaps poor health is a root cause historically, but the general level of dysfunction that characterizes underdevelopment has co-evolved with the disease environment, and may impart a degree of hysteresis even if population health improves. If the effects of health work through human capital, then the educational system might need reinforcement; if the effects work through sectoral change, then laws might need to be re-tooled; et cetera. Furthermore, the 'how' and 'when' might interact in ways that render the result irrelevant for policy. Suppose we live in a world with some degree of path dependence. It is possible that health mattered at some critical juncture, sending the economy down one path or another. If this path got locked in for some reason, the effects of poor health would still be felt today, but not because health depresses income per se. A well known variant of this idea is due to Acemoglu, Johnson, and Robinson (2001) , who argue that the health environment influenced how European powers chose to colonize areas that came under their influence in the past 500 years, in particular regarding the imposition of extractive institutions. The choice of institutions then influenced the path of development, by their argument, which affects income above and beyond any direct effect of health. (Their claim is actually stronger than this: that most if not all of the effect of health on income works through the choice of colonial institutions.) Variants of this story that do not involve institutions are possible. For example, models of economic geography can imply path dependence as well. Health and human capital might have influenced the choice of industry at some crucial point in history (e.g. the Industrial Revolution), which could then have been locked in by agglomeration economies. Put another way, even if it is completely correct to say that disease caused the current income to be lower, it cannot be inferred that treating disease will raise income by the same amount.
To learn about the latter issue, we need to analyze the response of income to changes in health.
Response to Large Health Shocks
An alternative approach to this question is to analyze, at the aggregate level, the impact of large shocks to health that come from epidemics or eradication efforts. The advantage of analyzing such shocks is that the causality most likely runs from health to income. The downside, however, is that the results from a given shock may not generalize to other settings.
First, I discuss some regional studies that trace the impact of health shocks on output. A classic result is by Schultz (1964) who studied the 1918 influenza pandemic and farm output in India. The flu killed substantial numbers, but left capital and land intact, and had little scarring effect on the adults who survived. Schultz therefore interprets the flu mortality as a decline in population only.
Comparing a few years before and after the epidemic (i.e., the relatively short run), he measures declines in output that were greater in areas that suffered more flu deaths. The magnitude of this relationship was consistent with a labor share of around 0.5. On the other hand, I estimate the aggregate (i.e., state level) responses to the above-mentioned campaigns against hookworm and malaria in the United States (Bleakley, 2007c) . Areas that stood to benefit from eradication saw slow increases in output that tracked the entrance into the workforce of cohorts exposed as children to the eradication campaigns. The estimated magnitudes are, if anything, larger than what I obtain in the earlier cohort-level estimates. This suggests little (net) crowding of fixed factors.
These results highlight once again how the response of income to health depends on the manner in which health improves. The Schultz study is about mortality reducing the population, which increases the ratio of labor to land. The eradication of tropical parasites in the US South is, on the other hand, mostly about childhood morbidity. We would therefore expect it to work through human capital rather than fixed-factor dilution. This contrast is evidence that we need to unpackage health if we want to understand its impact on income.
Next, I turn to a recent study by Acemoglu and Johnson (2007, henceforth "AJ") , who consider diffusion of technology circa 1950 that brought down mortality rates in poorer countries. AJ report that countries receiving the most favorable health shock experienced larger increases in life expectancy. With the increase in life expectancy came an increase in population, but a smaller and statistically insignificant rise in GDP. Thus the effect on output per capita was negative. They argue that other factors did not adjust when population grew.
The magnitude of the AJ result is larger than what should be expected based on the work discussed above. Qualitatively, their result is similar to the one reported by Schultz, perhaps as expected because both studies are tilted towards mortality not morbidity. If anything, we would expect the Schultz estimate to exhibit more diminishing returns to labor than AJ's, because AJ look at longer horizons (decades instead of years), over which time 'sticky' factors should have adjusted.
However, the magnitude of the AJ result is considerably larger: the ratio of the population to output elasticities is greater than 5. If we compare this to the bounds in Section 4.3, this implies a fixed-factor share of 0.8. This would be larger than Weil and Wilde's (2009) estimates of the land shares in income for any country today. The implied fixed-factor share would be larger still if the human-capital benefits of improved health are at all positive. Using a more general model, Ashraf, Lester, and Weil (2009, henceforth "ALW") report that the AJ result for GDP per capita is considerably worse than ALW's 'worst case' simulation.
As both AJ and ALW state, this muted response of output to population represents something of a puzzle. On the one hand, it may reflect compositional changes in the population. The reductions in infant mortality likely benefited the poor more than the rich, thus shifting the compositon of the population towards the children of the poor. 15 On the other hand, ALW suggest that it may reflect some yet-undiscovered specification problem.
In a recent comment, Bloom, Canning, and Fink (2009;  (4) where e is the natural log of life expectancy, and the standard error is in parentheses. This regression has an R 2 in excess of 0.96, which is a remarkable thing in and of itself. Perhaps not surprisingly, when BCF condition on initial life expectancy, this eliminates the AJ result by rendering the instrument insignificant in the first stage (which has ∆e 2000−1940 on the left-hand side). BCF argue that controlling for mean reversion is needed.
Including the initial life expectancy as a control might seem innocuous at first, but there are at least two problems with doing so. First, note that a typical interpretation of equation 4 is convergence: countries with lower initial life expectancy tended to experience faster growth in life expectancy subsequently. But the convergence in life expectancy during this period might be precisely the variance that we would want to analyze. A large intervention that benefits unhealthy areas in this period would induce this relationship. Consistent with this idea, AJ report that 1940 life expectancy strongly predicts changes in life expectancy in decades the decades that follow, while 1970 life expectancy is a much weaker predictor of subsequent changes in life expectancy.
Second, while some amount of convergence no doubt took place, we most likely cannot recover an unbiased estimate on e 1940 , and thus conditioning on it directly would bias the other parameter estimates. In the 1940s, many countries did not have adequate vital-registration systems. (Even the United States did not have a nationwide system of death registration until the 1930s.) Suppose that the true model for equation 4 is e * 1 − e * 0 = βe * 0 + * 1 but that we observe e t , which is the truth plus error: e t = e * t + η t . If the measurement error is 'classical', meaning that cov(e 0 , η t ) = 0 for t = 0, 1, then plimβ = θβ + (1 − θ)(−1), for θ ≡ vare * 0 vare * 0 +varη 0
. As the variance of η 0 increases, this estimate is biased towards -1.
Measurement error could also affect the AJ result. For long differences, the AJ instrument can be written as
whereM * j0 is baseline mortality for disease j times the predicted decline based on global advances in health technology,m * 0 is a aggregate over all the diseases j, and P and p are population, which is used to normalize the disease rates. The tildes on mortality and population variables reflect the fact that AJ used cities or regions in some cases to proxy for the country-level data. Capital letters denote levels and lower-case letters are natural logs. The reduced-form and first-stage equations are, respectively, ∆p * 1 = γz * 0 + ε * 1 and ∆e * 1 = αz * 0 + ω * 1 , where AJ assume the error terms are uncorrelated with z * 0 . Now suppose that we also observe population and baseline mortality with error, which seems more than likely. 16 Let measured population and baseline mortality variables be p t = p * t + ξ t . and m 0 = m * 0 + υ 0 . We expect, then, the instrumental variables (IV) estimate for the effect of life expectancy on population to converge to plim (γ/α) = cov (∆p 1 , z 0 ) cov (∆e 1 , z 0 ) = cov γz * 0 + ε * 1 + ξ 1 − ξ 0 , z * 0 +υ 0 −ξ 0 cov αz * 0 + ω * 1 + η 1 − η 0 , z * 0 +υ 0 −ξ 0 , where, again, the tildes reflect the possible use of sub-national data to proxy for a country's causespecific mortality rate. This probability limit does not, in general, go to γ/α.
Consider the sort of measurement error that arises in a few salient cases. First, census underenumeration was probably greater in poor countries, especially in the early part of the sample.
The ξ 0 would be correlated with GDP/capita, life expectancy, and (inversely with) mortality, and ξ 1 − ξ 0 would therefore be higher in less-developed countries. This would biasγ/α upwards.
Second, estimates of total mortality, life expectancy, and population growth were not generated independently, especially in underdeveloped countries. By construction, measurement errors would be correlated across variables. Specifically, cov(η 0 , υ 0 , ) < 0 and cov(ξ 1 − ξ 0 , υ 0 ) < 0, which would could biasγ/α up or down. Third, the use of sub-national proxies of mortality for some countries mean that mortality rates are mismeasured. This particular measurement error might just be classical, which would not bias the IV estimate. Moreover, the use of an alternate proxy of mortality is useful in that it attuenates the division bias that would have resulted from including the same (mis)measure of baseline population on both sides of the reduced-form equation for population.
(That is, any upward bias in the IV estimate is attenuated because presumably the cov(ξ 0 ,ξ 0 ) is less than var(ξ 0 ).)
How much would these data problems matter? It is hard to know without further understanding of the error properties of these data. The AJ result is some of the best evidence we have using cross-country comparisons, but further research is needed into whether reliable inferences can be made with such data.
CONCLUSIONS
This review is organized around the following question: how much does poor health hold back development? I focus on human capital and income. The micro evidence finds that childhood health is an input to producing other forms of human capital and that adult health depresses productivity as well. I use a standard model of human capital to tie together these various results together. Then, applying the Envelope Theorem to the model, I argue for a re-orientation of the micro literature; in short, we should be looking at outputs like income rather than inputs like time in school.
Next, I review the aggregate implications of micro estimates, which are complicated by health's effect on population size and other general-equilibrium issues. I argue that further research is needed in understanding how health improvements interact with other aspects of the economy, as well as how fertility responds to health shocks. I also review the macro evidence on this topic, which has taken the form of either cross-country comparisons or measuring the responses to large health shocks.
I conclude by reflecting on why we study interrelationships between health and development in the first place. Is the question whether health is the single factor that explains everything, leading to a 'magic bullet' intervention? This sets a pretty high standard, one that health (along with everything else) fails. Are we instead looking for do-able interventions that pass the cost/benefit test? If so, there seem to be many such examples in disease control.
